XML 23 R6.htm IDEA: XBRL DOCUMENT v3.25.0.1
CONDENSED CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($)
$ in Thousands
 6 Months Ended
Dec. 31, 2024
Dec. 31, 2023
Cash flows from operating activities    
Net income (loss) $ (19,862) $ (338,685)
Adjustments to reconcile net loss to net cash used in operating activities:    
Provision for losses 312,804 220,576
Amortization of premiums and discounts on loans (111,297) (87,979)
Gain on sales of loans (188,900) (86,987)
Gain on extinguishment of debt (82,418) 0
Changes in fair value of assets and liabilities 4,622 (4,912)
Amortization of commercial agreement assets 28,511 43,114
Amortization of debt issuance costs 12,990 12,758
Amortization of discount on securities available for sale (26,618) (23,122)
Commercial agreement warrant expense 194,039 210,615
Stock-based compensation 180,331 202,523
Depreciation and amortization 101,614 66,643
Other (2,151) 15,660
Change in operating assets and liabilities:    
Purchases and origination of loans held for sale (2,262,419) (2,244,895)
Proceeds from the sale of loans held for sale 2,262,441 2,262,184
Accounts receivable, net 143,781 (116,487)
Other assets (27,421) (41,669)
Accounts payable 9,607 31,203
Payable to third-party loan buyers (2,398) 80,715
Accrued interest payable 1,894 8,963
Accrued expenses and other liabilities (20,266) (36,995)
Net cash provided by operating activities 508,884 173,223
Cash flows from investing activities    
Purchases and origination of loans held for investment (15,051,906) (10,333,489)
Proceeds from the sale of loans held for investment 5,264,335 2,976,941
Principal repayments and other loan servicing activity 8,661,493 6,536,313
Additions to property, equipment and software (88,057) (74,564)
Purchases of securities available for sale (184,885) (193,322)
Proceeds from maturities and repayments of securities available for sale 720,570 482,029
Other investing cash inflows 14,383 (34,669)
Net cash used in investing activities (664,067) (640,761)
Cash flows from financing activities    
Proceeds from the issuance of convertible notes 920,000 0
Proceeds from the issuance of funding debt 7,893,354 6,439,713
Payment of debt issuance costs (23,070) (16,280)
Principal repayments of funding debt (7,548,552) (6,291,324)
Extinguishment of convertible debt (1,012,856) 0
Proceeds from issuance of notes and certificates by securitization trust 750,000 1,101,828
Principal repayments of notes issued by securitization trust 0 (528,279)
Proceeds from exercise of common stock options and warrants and contributions to ESPP 39,388 25,167
Repurchase of common stock (250,000) 0
Payments of tax withholding for stock-based compensation (158,543) (75,674)
Net cash provided by financing activities 609,721 655,151
Effect of exchange rate changes on cash, cash equivalents and restricted cash (12,780) 421
Net increase in cash, cash equivalents and restricted cash 441,758 188,034
Cash, cash equivalents and restricted cash, beginning of period 1,295,399 1,259,944
Cash, cash equivalents and restricted cash, end of period 1,737,157 1,447,978
Reconciliation to amounts on consolidated balance sheets (as of period end)    
Cash and cash equivalents 1,200,381 1,036,719
Restricted cash 536,776 411,259
Total cash, cash equivalents and restricted cash 1,737,157 1,447,978
Supplemental disclosures of cash flow information    
Cash payments for interest expense 201,129 142,449
Cash paid for operating leases 8,322 8,251
Cash paid for income taxes 1,110 571
Supplemental disclosures of non-cash investing and financing activities    
Stock-based compensation included in capitalized internal-use software 94,186 68,460
Securities retained under unconsolidated securitization transactions $ 41,940 $ 0